<--- Back to Details
First PageDocument Content
Cytokines / Cancer research / Nitriles / Organofluorides / CCL2 / LNCaP / Prostate cancer / MDV3100 / STAT3 / Biology / Medicine / Cell lines
Date: 2013-08-08 09:56:46
Cytokines
Cancer research
Nitriles
Organofluorides
CCL2
LNCaP
Prostate cancer
MDV3100
STAT3
Biology
Medicine
Cell lines

Microsoft PowerPoint - Figure MQ[removed]

Add to Reading List

Source URL: www.nature.com

Download Document from Source Website

File Size: 1,79 MB

Share Document on Facebook

Similar Documents

Prostate cancer / Organofluorides / Prostate / Androgen receptor / MDV3100 / Galeterone / Anatomy / Biology / Medicine

Award ID: CP130020 Project Title: Androgen Receptor N-Terminus Blocker Program for Prostate Cancer Award Mechanism: Company Relocation

DocID: 19pfm - View Document

Nitriles / Organofluorides / Benzoates / Carbamates / Abiraterone / MDV3100 / Prostate cancer / Docetaxel / Bicalutamide / Chemistry / Organic chemistry / Antiandrogens

5.5 ENZALUTAMIDE, capsule, 40 mg, Xtandi®, Astellas Pharma Australia Pty Ltd, Purpose of Application Authority required (Streamlined) listing for enzalutamide for treatment of metastatic prostate cancer after treatment

DocID: 17GTi - View Document

Nitriles / Organofluorides / Benzoates / Carbamates / Abiraterone / MDV3100 / Prostate cancer / Docetaxel / Bicalutamide / Chemistry / Organic chemistry / Antiandrogens

PDF Document

DocID: 16Qjm - View Document

Cytokines / Cancer research / Nitriles / Organofluorides / CCL2 / LNCaP / Prostate cancer / MDV3100 / STAT3 / Biology / Medicine / Cell lines

Microsoft PowerPoint - Figure MQ[removed]

DocID: ZzdJ - View Document

Cancer treatments / Prostate-specific antigen / Prostate / MDV3100 / Docetaxel / Benign prostatic hyperplasia / Institute of Cancer Research / Management of cancer / Management of prostate cancer / Medicine / Prostate cancer / Abiraterone

Queensland Prostate Cancer News This magazine is a publication of the Queensland Chapter, Prostate Cancer Foundation of Australia. Letter from the Editor

DocID: YHLd - View Document